Novartis' soon-to-be spun off generics division Sandoz is betting on biosimilars, copies of high-priced drugs used to treat illnesses such as rheumatoid arthritis and cancer, to fuel its future as a standalone company, executives said on Thursday. The short values listed hinein PropertyValueAliases.txt for the Age property for assigned (designated) https://rylanhnsxd.wiki-racconti.com/7109481/eine_geheimwaffe_für_category_general